DOCSLIB.ORG

Acute Viral Hepatitis- Beyond A, B and C* Venancio Avancini Ferreira

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Acute Viral Hepatitis- Beyond A, B and C* Venancio Avancini Ferreira Acute Viral Hepatitis- Beyond A, B and C* Venancio Avancini Ferreira Alves, MD, PhD Professor & Chairman, Department of Pathology University of Sao Paulo School of Medicine, Sao Paulo, Brazil As defined by Neil Theise at the 9th edition of Robbins (1), “Hepatitis” stands for histologic patterns of lesions found in the livers infected by hepatotropic viruses , by other viruses leading to a liver inflammation in the context of systemic infection, or due to autoimmune , drug or toxins involving the liver. Pathological findings encompasses a set of diffuse necro-inflammation of the liver, presenting heterogeneous distribution. In acute hepatitis , necro-inflammation is more intense in the parenchyma, whereas in chronic forms the inflammation is more relevant at the portal tract and at the porto-parenchymal interface (acinar zone 1). The present review is based on our recent comprehensive approach to acute viral hepatitis at Saxena´s Practical Hepatic Pathology (2). Herein , we will target especially the histological patterns of injury in acute viral hepatitis, describing aspects related to : 1. The so-called “hepatotropic viruses A, B, C, D and E” ; 2. Viruses responsible for the “icteric hemorrhagic fevers” (dengue, hantavirus, yellow fever). A brief mention to viruses causing hepatitis in immunosuppressed patients will also be presented. Although globalization has exposed travelers to previously unexpected agents, potentially disseminating viruses from different regions of the world, remarkable differences in incidence of each type of viral hepatitis still remain . A recent series of 206 cases of acute viral hepatitis from India 3 identified HEV in 95 cases, HAV in 36, HBV in 18 and mixed infections of these viruses in additional 27 cases. HCV was detected in only one patient. The other 29 cases were ascribed to CMV or EBV. In the USA, official reports of acute hepatitis from CDC for the year 2013 include 1,781 cases of HAV, decreasing to 1,239 in 2014. Notifications of acute hepatitis due to HBV were 3,050 in 2013 and 2,791 in 2014. Acute hepatitis due to HCV totalized 2,138 in 2013, rising to 2,194 in 2014. No data regarding HEV is depicted and, elsewhere in the site, CDC comments that, in the USA, HEV is believed to be uncommon . When symptomatic hepatitis E does occur, it is usually the result of travel to a developing country where hepatitis E is endemic. 4 Acute liver failure (ALF) may result from viral hepatitis. In 2014, the CDC reported 76 cases of deaths in the US ascribed to HAV 4 . Deaths due to acute hepatitis B were reported in 13 cases. However, chronic Hepatitis B was considered the cause of death of 1,843 patients. The CDC report did not mention death due to Acute Hepatitis C, but Chronic Hepatitis C was considered the cause of death of 19,659 patients 4 Although not mentioned at the CDC report 4 , in other countries acute liver failure is mentioned in 0.1% to 4.0% of patients infected with hepatitis E, with a predilection for pregnant women, 30% of whom may develop acute liver failure.5 _______________________________________________________________________________ PATTERNS OF LESIONS IN ACUTE VIRAL HEPATITIS Lobular parenchymal lesions are predominant, with variable number of swollen/ballooned hepatocytes. Small foci of lymphocytes, macrophages and plasma cells, even in early infection, surround damaged hepatocytes or fragments of dead hepatocytes, a lesion known as lytic necrosis or spotty necrosis .6 Individual hepatocytic death due to apoptosis may also be numerous, known as acidophilic bodies and Councilman-Rocha Lima bodies. Cellular remnants phagocyted by Kupffer cells may be seen as iron deposits on Perls stain, useful hints for the diagnosis of resolving acute hepatitis when H&E aspects are bland. Portal edema and variable amounts of mononuclear infiltrate are usually less impressive than parenchymal lesions. Bile duct injury is usually mild, although acute hepatitis E may show variable degrees of cholangitis7. Mild cholestasis may be seen in acute hepatitis, with bile pigment found in the cytoplasm of hepatocytes or in biliary canaliculi. Although more relevant biliary changes may be seen , especially in elder patients, this finding should require the differential diagnosis with drug-induced injury or, exceptionally, even with bile duct obstruction. Hepatocytes at the interface with portal tract are usually not damaged, although in Hepatitis A, lymphocytes spill over the limiting plate. Since portal fibrosis and neoangiogenesis are not features of acute hepatitis, when patterns of both acute and chronic hepatitis coexist, the pathologist must consider the possibility of an acute viral infection occurring in an already inflamed liver. An important example for such finding is hepatitis D virus (HDV) superinfection of livers chronically infected by HBV.8 In most cases of acute hepatitis, especially those due to hepatitis A and E, the loss of individual hepatocytes due to apoptosis and spotty necrosis do not disturb trabecular architecture and, once viral infection resolves, usually within 2 – 4 months after infection, regeneration from neighboring adult hepatocytes leads to complete restoration of structure and function of the liver. In some cases of acute viral hepatitis, groups of hepatocytes die, resulting in collapse of reticulin framework, known as confluent necrosis.6,9 When confluent necrosis links centrilobular venules to the neighboring ones, a "vascular bridge" ensues ("central-central bridging" or "central-portal bridging"). Boyer and Klatskin suggested that confluent necrosis linking central veins to portal tracts might lead to a presinusoidal-postsinusoidal shunt,10 with a high risk of evolution to cirrhosis. This debate is still open for further studies especially assessing the liver microvasculature. An infrequent clinical condition resulting from acute viral hepatitis is "fulminant hepatitis," with liver failure occurring few weeks after the onset of acute hepatitis. In this setting, confluent necrosis may become very extensive , leading to submassive or even massive necrosis. Due to the irregular distribution of necrosis, histologic features from needle liver biopsies do not predict clinical outcome in such instances11 Extensive necrosis may be mistaken with fibrosis; the distinction can be aided by silver impregnation stains such as the Gomori silver stain. Confluent necrosis leads to approximation of reticulin fibers (collagen III fibers) due to parenchymal collapse, whereas chronic active fibrogenesis leads to deposition of both collagen III and collagen I fibers. Collagen III appears as narrow black fibrils (reticulin fibrils), whereas collagen I bands appear brown . Chronic fibrogenesis is accompanied by production of elastic fibers,visualized by the Shikata orcein, van Gieson, or Weigert stain, whereas acute collapse lack elastic fibers.12 Liver regeneration, in most cases with predominance apoptosis and spotty necrosis, is based on neighboring mature hepatocytes, completely restoring lobular architecture. In early biopsies, this appear as a widening of liver cell trabeculae , with "double cell plates" of hepatocytes (sometimes binucleated , or multinucleated) or appearing as "pseudoacinar" .When regeneration from adult hepatocytes is not effective, activation of a common progenitor epithelial cell of the liver, purported to be located in the canals of Hering at periportal regions, may lead to a network of small tubular- canalicular structures reminiscent of biliary ductules positive for CK19. These are embedded in variable amounts of collagen and may lead to a fibrous scar as in cases of submassive/massive hepatic necrosis13 The fate of liver microarchitecture after acute hepatitis depends on the etiologic agent as well as the patterns of necrosis and regeneration. Hepatic structure and function are usually completely restored in a few months in cases where parenchymal damage consisted only of apoptosis or spotty necrosis, whereas variable degrees of fibrous scars may develop in cases with more extensive confluent or submassive/massive necrosis, even after resolution of the infection. Histologic Hints to the Causative Virus Nowadays, the etiological diagnosis of acute hepatitis is achieved by serology, with sensitive tests detecting viral antigens in Hepatitis B or antibodies to viral proteins in Hepatitis A, C, D and E. Molecular tests, most of them based on Polymerase Chain Reaction (PCR), are also important for the diagnosis of ongoing infection by these viruses and also for other agents in icteric hemorrhagic syndromes and in viruses infecting immunocompromised patients. Although most histologic patterns are common to all types of acute hepatitis, some features are more frequently associated with specific viruses. Hepatitis A Lobular features are usually predominant, with spotty necrosis and many apoptotic bodies. Interestingly, the portal infiltrate may be impressive, with plasma cells and lymphocytes, frequently “spilling over” into the limiting plate. Information of serological positivity for HAV is important for the differential diagnosis with chronic interface hepatitis, especially in cases with prolonged or relapsing disease, which may last for more than 6 months. Minor cholestasis may be seen in these cases.14 Hepatitis E Hepatitis E infection is endemic in the India, sub-Saharan Africa, and Mexico, where infection is waterborne. More recently, food-born zoonotic disease or blood-born infections have been published in the United States, France, Japan and England.15,16
Load more

Recommended publications
  • Impact of HIV on Gastroenterology/Hepatology
    Core Curriculum: Impact of HIV on Gastroenterology/Hepatology AshutoshAshutosh Barve,Barve, M.D.,M.D., Ph.D.Ph.D. Gastroenterology/HepatologyGastroenterology/Hepatology FellowFellow UniversityUniversityUniversity ofofof LouisvilleLouisville Louisville Case 4848 yearyear oldold manman presentspresents withwith aa historyhistory ofof :: dysphagiadysphagia odynophagiaodynophagia weightweight lossloss EGDEGD waswas donedone toto evaluateevaluate thethe problemproblem University of Louisville Case – EGD Report ExtensivelyExtensively scarredscarred esophagealesophageal mucosamucosa withwith mucosalmucosal bridging.bridging. DistalDistal esophagealesophageal nodulesnodules withwithUniversity superficialsuperficial ulcerationulceration of Louisville Case – Esophageal Nodule Biopsy InflammatoryInflammatory lesionlesion withwith ulceratedulcerated mucosamucosa SpecialSpecial stainsstains forfor fungifungi revealreveal nonnon-- septateseptate branchingbranching hyphaehyphae consistentconsistent withwith MUCORMUCOR University of Louisville Case TheThe patientpatient waswas HIVHIV positivepositive !!!! University of Louisville HAART (Highly Active Anti Retroviral Therapy) HIV/AIDS Before HAART After HAART University of Louisville HIV/AIDS BeforeBefore HAARTHAART AfterAfter HAARTHAART ImmuneImmune dysfunctiondysfunction ImmuneImmune reconstitutionreconstitution OpportunisticOpportunistic InfectionsInfections ManagementManagement ofof chronicchronic ¾ Prevention diseasesdiseases e.g.e.g. HepatitisHepatitis CC ¾ Management CirrhosisCirrhosis NeoplasmsNeoplasms
    [Show full text]
  • Viral Hepatitis Testing Effective Date: January 1, 2012
    Viral Hepatitis Testing Effective Date: January 1, 2012 Scope This guideline provides guidance for the use of laboratory tests to diagnose acute and chronic viral hepatitis in adults (> 19 years) in the primary care setting. General Considerations for Ordering Laboratory Tests Prior to ordering tests for hepatitis, consider the patient’s history, age, risk factors (see below), hepatitis vaccination status, and any available previous hepatitis test results. Risk Factors for Viral Hepatitis include: • Substance use (includes sharing drug snorting, smoking or injection equipment) • High-risk sexual activity or sexual partner with viral hepatitis • Travel to or from high-risk hepatitis endemic areas or exposure during a local outbreak • Immigration from hepatitis B and/or C endemic countries • Household contact with an infected person especially if personal items (e.g., razors, toothbrushes, nail clippers) are shared • Recipient of unscreened blood products* • Needle-stick injury or other occupational exposure (e.g., healthcare workers) • Children born to mothers with chronic hepatitis B or C infection • Attendance at daycare • Contaminated food or water (hepatitis A only) • Tattoos and body piercing • History of incarceration • HIV or other sexually transmitted infection • Hemodialysis *screening of donated blood products for hepatitis C (anti-HCV) began in 1990 in Canada.1 Types of Viral Hepatitis Hepatitis A: causes acute but not chronic hepatitis Hepatitis B: causes acute and chronic hepatitis Hepatitis C: causes chronic hepatitis but rarely manifests as acute hepatitis Hepatitis D: rare and only occurs in patients infected with hepatitis B Hepatitis E: clinically similar to hepatitis A, mostly restricted to endemic areas and occasionally causes chronic infection in immunosuppressed people Others: e.g.
    [Show full text]
  • Steatosis in Hepatitis C: What Does It Mean? Tarik Asselah, MD, Nathalie Boyer, MD, and Patrick Marcellin, MD*
    Steatosis in Hepatitis C: What Does It Mean? Tarik Asselah, MD, Nathalie Boyer, MD, and Patrick Marcellin, MD* Address Steatosis *Service d’Hépatologie, Hôpital Beaujon, Mechanisms of steatosis 100 Boulevard du Général Leclerc, Clichy 92110, France. Hepatic steatosis develops in the setting of multiple E-mail: [email protected] clinical conditions, including obesity, diabetes mellitus, Current Hepatitis Reports 2003, 2:137–144 alcohol abuse, protein malnutrition, total parenteral Current Science Inc. ISSN 1540-3416 Copyright © 2003 by Current Science Inc. nutrition, acute starvation, drug therapy (eg, corticosteroid, amiodarone, perhexiline, estrogens, methotrexate), and carbohydrate overload [1–4,5••]. Hepatitis C and nonalcoholic fatty liver disease (NAFLD) are In the fed state, dietary triglycerides are processed by the both common causes of liver disease. Thus, it is not surprising enterocyte into chylomicrons, which are secreted into the that they can coexist in the same individual. The prevalence of lymph. The chylomicrons are hydrolyzed into fatty acids by steatosis in patients with chronic hepatitis C differs between lipoprotein lipase. These free fatty acids are transported to the studies, probably reflecting population differences in known liver, stored in adipose tissue, or used as energy sources by risk factors for steatosis, namely overweight, diabetes, and muscles. Free fatty acids are also supplied to the liver in the dyslipidemia. The pathogenic significance of steatosis likely form of chylomicron remnants, which are then hydrolyzed by differs according to its origin, metabolic (NAFLD or non- hepatic triglyceride lipase. During fasting, the fatty acids sup- alcoholic steatohepatitis) or virus related (due to hepatitis C plied to the liver are derived from hydrolysis (mediated by a virus genotype 3).
    [Show full text]
  • Review Article Alcohol Induced Liver Disease
    J Clin Pathol: first published as 10.1136/jcp.37.7.721 on 1 July 1984. Downloaded from J Clin Pathol 1984;37:721-733 Review article Alcohol induced liver disease KA FLEMING, JO'D McGEE From the University of Oxford, Nuffield Department ofPathology, John Radcliffe Hospital, Oxford OX3 9DU, England SUMMARY Alcohol induces a variety of changes in the liver: fatty change, hepatitis, fibrosis, and cirrhosis. The histopathological appearances of these conditions are discussed, with special atten- tion to differential diagnosis. Many forms of alcoholic liver disease are associated with Mallory body formation and fibrosis. Mallory bodies are formed, at least in part, from intermediate filaments. Associated changes in intermediate filament organisation in alcoholic liver disease also occur. Their significance in the pathogenesis of hepatocyte death may be related to abnormalities in messenger RNA function. The mechanisms underlying hepatic fibrogenesis are also discussed. Although alcohol has many effects on the liver, all formed after some period of alcohol abstinence, except cirrhosis are potentially reversible on cessa- alcohol related changes may not be seen. Accord- tion of alcohol ingestion. Cirrhosis is irreversible ingly, we shall consider the morphological changes and usually ultimately fatal. It is therefore important associated with alcohol abuse under the headings in to determine what factors are responsible for Table 1. development of alcohol induced cirrhosis, especially In the second part, the pathogenesis of alcohol since only 17-30% of all alcoholics become' cirrho- induced liver disease will be discussed, but this will tic.' This is of some urgency now, since there has deal only with the induction of alcoholic hepatitis, been an explosive increase in alcohol consumption fibrosis, and cirrhosis-that is, chronic alcoholic http://jcp.bmj.com/ in the Western World, particularly affecting young liver disease-and not with fatty change, for two people, resulting in a dramatic increase in the inci- reasons.
    [Show full text]
  • In Colorectal Cancer
    Article Evaluation of Adjuvant Chemotherapy-Associated Steatosis (CAS) in Colorectal Cancer Michelle C. M. Lee 1,2 , Jacob J. Kachura 3, Paraskevi A. Vlachou 1,2, Raissa Dzulynsky 1, Amy Di Tomaso 3, Haider Samawi 1,2, Nancy Baxter 1,2 and Christine Brezden-Masley 1,3,4,* 1 St. Michael’s Hospital, 30 Bond St, Toronto, ON M5B 1W8, Canada; [email protected] (M.C.M.L.); [email protected] (P.A.V.); [email protected] (R.D.); [email protected] (H.S.); [email protected] (N.B.) 2 Medical Sciences Building, 1 King’s College Circle, University of Toronto, Toronto, ON M5S 1A8, Canada 3 Mount Sinai Hospital, 1284-600 University Avenue, Toronto, ON M5G 1X5, Canada; [email protected] (J.J.K.); [email protected] (A.D.T.) 4 Lunenfeld-Tanenbaum Research Institute, 600 University Ave, Toronto, ON M5G 1X5, Canada * Correspondence: [email protected]; Tel.: +416-586-8605; Fax: +416-586-8659 Abstract: Chemotherapy-associated steatosis is poorly understood in the context of colorectal can- cer. In this study, Stage II–III colorectal cancer patients were retrospectively selected to evaluate the frequency of chemotherapy-associated steatosis and to determine whether patients on statins throughout adjuvant chemotherapy develop chemotherapy-associated steatosis at a lower frequency. Baseline and incident steatosis for up to one year from chemotherapy start date was assessed based on radiology. Of 269 patients, 76 (28.3%) had steatosis at baseline. Of the remaining 193 cases, patients receiving adjuvant chemotherapy (n = 135) had 1.57 (95% confidence interval [CI], 0.89 to 2.79) times the adjusted risk of developing steatosis compared to patients not receiving chemotherapy (n = 58).
    [Show full text]
  • Prevention & Control of Viral Hepatitis Infection
    Prevention & Control of Viral Hepatitis Infection: A Strategy for Global Action © World Health Organization 2011. All rights reserved. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by WHO to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either express or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. Table of contents Disease burden 02 What is viral hepatitis? 05 Prevention & control: a tailored approach 06 Global Achievements 08 Remaining challenges 10 World Health Assembly: a mandate for comprehensive prevention & control 13 WHO goals and strategy
    [Show full text]
  • Symmetrical Peripheral Gangrene Associated with Low Output Cardiac Failure
    Tower Health Scholar Commons @ Tower Health Reading Hospital Internal Medicine Residency Internal Medicine Residency 7-17-2019 Symmetrical Peripheral Gangrene Associated with Low Output Cardiac Failure. Sijan Basnet Reading Hospital-Tower Health Priya Rajagopalan Thomas Jefferson University Hospital Rashmi Dhital Reading Hospital-Tower Health Ataul Qureshi Thomas Jefferson University Hospital Follow this and additional works at: http://scholarcommons.towerhealth.org/ gme_int_med_resident_program_read Part of the Cardiology Commons Recommended Citation Basnet, S., Rajagopalan, P., Dhital, R., & Qureshi, A. (2019). Symmetrical Peripheral Gangrene Associated with Low Output Cardiac Failure.. Medicina (Kaunas, Lithuania), 55 (7) https://doi.org/10.3390/ medicina55070383. This Article is brought to you for free and open access by the Internal Medicine Residency at Scholar Commons @ Tower Health. It has been accepted for inclusion in Reading Hospital Internal Medicine Residency by an authorized administrator of Scholar Commons @ Tower Health. For more information, please contact [email protected]. medicina Case Report Symmetrical Peripheral Gangrene Associated with y Low Output Cardiac Failure Sijan Basnet 1,* , Priya Rajagopalan 2, Rashmi Dhital 1 and Ataul Qureshi 2 1 Department of Medicine, Reading Hospital and Medical Center, West Reading, PA 19611, USA 2 Thomas Jefferson University Hospital, 1025 Walnut Street, Philadelphia, PA 19107, USA * Correspondence: [email protected]; Tel.: +484-628-8255 The abstract was accepted for poster presentation at “Heart Failure Society of America 2018 Annual y Meeting” and was published in Journal of Cardiac Failure. Received: 15 January 2019; Accepted: 15 July 2019; Published: 17 July 2019 Abstract: Symmetrical peripheral gangrene (SPG) is a rare entity characterized by ischemic changes of the distal extremities with maintained vascular integrity.
    [Show full text]
  • Hepatitis A, B, and C: Learn the Differences
    Hepatitis A, B, and C: Learn the Differences Hepatitis A Hepatitis B Hepatitis C caused by the hepatitis A virus (HAV) caused by the hepatitis B virus (HBV) caused by the hepatitis C virus (HCV) HAV is found in the feces (poop) of people with hepa- HBV is found in blood and certain body fluids. The virus is spread HCV is found in blood and certain body fluids. The titis A and is usually spread by close personal contact when blood or body fluid from an infected person enters the body virus is spread when blood or body fluid from an HCV- (including sex or living in the same household). It of a person who is not immune. HBV is spread through having infected person enters another person’s body. HCV can also be spread by eating food or drinking water unprotected sex with an infected person, sharing needles or is spread through sharing needles or “works” when contaminated with HAV. “works” when shooting drugs, exposure to needlesticks or sharps shooting drugs, through exposure to needlesticks on the job, or from an infected mother to her baby during birth. or sharps on the job, or sometimes from an infected How is it spread? Exposure to infected blood in ANY situation can be a risk for mother to her baby during birth. It is possible to trans- transmission. mit HCV during sex, but it is not common. • People who wish to be protected from HAV infection • All infants, children, and teens ages 0 through 18 years There is no vaccine to prevent HCV.
    [Show full text]
  • Fructose Diets on the Liver of Male Albino Rat and the Proposed Underlying Mechanisms S.M
    Folia Morphol. Vol. 78, No. 1, pp. 124–136 DOI: 10.5603/FM.a2018.0063 O R I G I N A L A R T I C L E Copyright © 2019 Via Medica ISSN 0015–5659 journals.viamedica.pl The differential effects of high-fat and high- -fructose diets on the liver of male albino rat and the proposed underlying mechanisms S.M. Zaki1, 2, S.A. Fattah1, D.S. Hassan1 1Department of Anatomy and Embryology, Faculty of Medicine, Cairo University, Cairo, Egypt 2Fakeeh College for Medical Sciences, Jeddah, Saudi Arabia [Received: 23 May 2108; Accepted: 26 June 2018] Background: The Western-style diet is characterised by the high intake of energy- -dense foods. Consumption of either high-fructose diet or saturated fat resulted in the development of metabolic syndrome. Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the metabolic syndrome. Many researchers studied the effect of high-fat diet (HFD), high-fructose diet (HFruD) and high-fructose high-fat diet (HFHF) on the liver. The missing data are the comparison effect of these groups i.e. are effects of the HFHF diet on the liver more pronounced? So, this study was designed to compare the metabolic and histopathological effect of the HFD, HFruD, and HFHF on the liver. The proposed underlying mechanisms involved in these changes were also studied. Materials and methods: Twenty four rats were divided into four groups: con- trol, HFD, HFruD, and HFHF. Food was offered for 6 weeks. Biochemical, light microscopic, immunohistochemical (Inducible nitric oxide synthase [iNOS] and alpha-smooth muscle actin [α-SMA]), real-time polymerase chain reaction (gene expression of TNF-α, interleukin-6, Bax, BCL-2, and caspase 3), histomorphometric analysis and oxidative/antioxidative markers (thiobarbituric acid reactive substances [TBARS], malondialdehyde [MDA]/glutathione [GSH] and superoxide dismutase [SOD]) were done.
    [Show full text]
  • Acute Pancreatitis, Non-Alcoholic Fatty Pancreas Disease, and Pancreatic Cancer
    JOP. J Pancreas (Online) 2017 Sep 29; 18(5):365-368. REVIEW ARTICLE The Burden of Systemic Adiposity on Pancreatic Disease: Acute Pancreatitis, Non-Alcoholic Fatty Pancreas Disease, and Pancreatic Cancer Ahmad Malli, Feng Li, Darwin L Conwell, Zobeida Cruz-Monserrate, Hisham Hussan, Somashekar G Krishna Division of Gastroenterology, Hepatology and Nutrition, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA ABSTRACT Obesity is a global epidemic as recognized by the World Health Organization. Obesity and its related comorbid conditions were recognized to have an important role in a multitude of acute, chronic, and critical illnesses including acute pancreatitis, nonalcoholic fatty pancreas disease, and pancreatic cancer. This review summarizes the impact of adiposity on a spectrum of pancreatic diseases. INTRODUCTION and even higher mortality in the setting of AP based on multiple reports [8, 9, 10, 11, 12]. Despite the rising incidence Obesity is a global epidemic as recognized by the World of AP over the past two decades, there has been a decrease Health Organization [1]. One third of the world’s population in its overall mortality rate without any obvious decrement is either overweight or obese, and it has doubled over the in the mortality rate among patients with concomitant AP past two decades with an alarming 70% increase in the and morbid obesity [12, 13]. Several prediction models and prevalence of morbid obesity from year 2000 to 2010 [2, risk scores were proposed to anticipate the severity and 3, 4]. Obesity and its related comorbid conditions were prognosis of patient with AP; however, their clinical utility recognized to have an important role in a multitude of is variable, not completely understood, and didn’t take acute, chronic, and critical pancreatic illnesses including obesity as a major contributor into consideration despite the acute pancreatitis, non-alcoholic fatty pancreas disease, aforementioned association [14].
    [Show full text]
  • Eponyms in Digestive System Pathology
    Panacea Journal of Medical Sciences 2020;10(2):58–67 Content available at: https://www.ipinnovative.com/open-access-journals Panacea Journal of Medical Sciences Journal homepage: www.ipinnovative.com Review Article Eponyms in digestive system pathology Ahmad Al Malki1, Hassan Al Solami2, Khalid Al Aboud3,*, Wafa Al Joaid3, Saleha Al Asmary4 1Dept. of Surgery, King Faisal Hospital, Makkah, Saudi Arabia 2Dept. of Gastroenterology, King Faisal Hospital, Makkah, Saudi Arabia 3Dept. of Public Health, King Faisal Hospital, Makkah, Saudi Arabia 4Nursing College, King Saud University, Riyadh, Saudi Arabia ARTICLEINFO ABSTRACT Article history: Eponyms are known type of medical terminology. This mini-review provide highlights on some of the Received 04-05-2020 eponyms of the digestive system pathology. Accepted 06-05-2020 Available online 26-08-2020 © 2020 Published by Innovative Publication. This is an open access article under the CC BY-NC license (https://creativecommons.org/licenses/by-nc/4.0/) Keywords: Diseases Eponyms Gastroenterology 1. Introduction An eponym is a person, place, or thing after whom or which someone or something is named. There are several anatomical and pathological eponyms in the digestive systems. 1–4 We have reviewed selected eponyms of the digestive system pathology, and present it in a tabulation form in table.1. 5–41 The remarks surrounding the terms and eponyms in the digestive system are no different from those encountered in medicine in general. We are not interested to mention these are remarks, as these have been discussed extentensively in the medical literature. However, we list few examples. Some of the eponyms are no longer in use.
    [Show full text]
  • Special Activities
    59th Annual International Conference of the Wildlife Disease Association Abstracts & Program May 30 - June 4, 2010 Puerto Iguazú Misiones, Argentina Iguazú, Argentina. 59th Annual International Conference of the Wildlife Disease Association WDA 2010 OFFICERS AND COUNCIL MEMBERS OFFICERS President…………………………….…………………...………..………..Lynn Creekmore Vice-President………………………………...…………………..….Dolores Gavier-Widén Treasurer………………………………………..……..……….….……..…….Laurie Baeten Secretary……………………………………………..………..……………….…Pauline Nol Past President…………………………………………………..………Charles van Riper III COUNCIL MEMBERS AT LARGE Thierry Work Samantha Gibbs Wayne Boardman Christine Kreuder Johnson Kristin Mansfield Colin Gillin STUDENT COUNCIL MEMBER Terra Kelly SECTION CHAIRS Australasian Section…………………………..……………………….......Jenny McLelland European Section……………………..………………………………..……….….Paul Duff Nordic Section………………………..………………………………..………….Erik Ågren Wildlife Veterinarian Section……..…………………………………..…………Colin Gillin JOURNAL EDITOR Jim Mills NEWSLETTER EDITOR Jenny Powers WEBSITE EDITOR Bridget Schuler BUSINESS MANAGER Kay Rose EXECUTIVE MANAGER Ed Addison ii Iguazú, Argentina. 59th Annual International Conference of the Wildlife Disease Association ORGANIZING COMMITTEE Executive President and Press, media and On-site Volunteers Conference Chair publicity Judy Uhart Marcela Uhart Miguel Saggese Marcela Orozco Carlos Sanchez Maria Palamar General Secretary and Flavia Miranda Program Chair Registrations Elizabeth Chang Reissig Pablo Beldomenico Management Patricia Mendoza Hebe Ferreyra
    [Show full text]